That is essential, because the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (legacy report prediction). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement practically nobody saw. However it's going to have profound implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (social media). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably prior to going higher - bleeding edge. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. But that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous fantastic personal companies on the edge of striking the general public markets And I have actually been dealing with a brand-new method for you to invest even prior to these business go public.
This chance has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers know that tech isn't our typical beat (jeff brown latest prediction). And when it pertains to tech investing, we leave it to the specialists. Luckily, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we understand (jeff brown 1 biotech company). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid growth and creating extraordinary chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown biotech genome sequencing. However in spite of what numerous readers may think, this is a trend that's just beginning. Although the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown tech stock 2021). Losing two months of manufacturing and sales really affects how numerous 5G devices are offered in the fiscal year. When you think about all of that, offering 250 million units is impressive. More notably, the hold-ups triggered by the pandemic created a heap of suppressed need. Which demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be delivered in 2021 - social media. Which's not my only 5G prediction When I've discussed 5G in the past, I've explained its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage 3, 5G services begin to be used (democratic republic). That's when we start to see applications operating on 5G networks. Think of things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage Three by this summer. This starts something of a virtuous cycle: Many people don't truly care about the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open up a suite of extraordinary applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities going forward will be massive. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a comparable concept but with our genetic code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For many years, CRISPR was primarily a specific niche innovation that wasn't well understood. And during that time, there were truly just three companies operating in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole industry is effectively a greenfield chance.
There's room for lots of companies to exist in this area. jeff brown predictions 2021. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is very important since the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug therapies produced utilizing this technology. This was one of those breakthroughs that nearly nobody observed. However it's going to have extensive implications for treating illness. And, naturally, there will be lots of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps substantially before going higher. I've been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - jeff brown prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown investor prediction. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date as of February 2021, but we could not separately validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding perspective on the market. He's always on the hunt for new chances, and he shares many of his best picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully anticipated some of the biggest economic events of the previous twenty years. Although he does not appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate predictions have actually made him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent monetary research publisher. Brownstone Research study offers several research services with a large range of specializations - jeff brown 2020 predictions.
The business is also associated with Bonner & Partners, another well-respected research study publisher - legacy report prediction. On its website, Brownstone says its objective is to supply retail financiers with professional-grade research: "For too long, the very best investment research has actually not been readily available to specific financiers. It has been normally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. last year. The objective of Brownstone Research study is to make that sort of exclusive research offered to any financiers seeking to get an edge in the markets. The objective is simple to provide special and lucrative investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the firm's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. korean actress. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. jeff brown genome sequencing. might be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two advanced innovations: synthetic intelligence and electric vehicles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electrical automobiles and self-driving cars and truck stocks have actually been substantial this year, however the Wall Street machine has been big on buzz without much tangible outcome. Regardless of an extreme boost in competition over the past couple of years, Brown still thinks Musk has the very best opportunity of putting everything together.
tech could be the magic string that connects all of it together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transportation. Essentially, this technology would enable you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the vehicle and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the revenues. It sounds ridiculous, but it might be closed than you think.